TSRLabs


TSRLabs is a woman-owned preclinical contract research organization (CRO) based in Ann Arbor, Michigan. The company provides integrated early-stage development services — including formulation development, high-sensitivity bioanalysis, pharmacokinetics/ADME, exploratory toxicology, strategic consulting, and drug delivery system development — to pharmaceutical, biotechnology, academic, and government partners. TSRLabs emphasizes data generation and risk reduction to inform candidate-advancement decisions in preclinical development.

Industries

Biotechnology
Clinical Trials
Pharmaceutical
Therapeutics
Pharmaceutical Manufacturing

Nr. of Employees

small (1-50)

TSRLabs

Ann Arbor, Michigan, United States


Products

Proprietary microneedle / microarray patch (MAP) delivery platform

A transdermal microneedle/microarray patch platform under development for weekly or other sustained dosing applications; development includes licensing, co-development, and grant-supported projects.

sHDL (synthetic high-density lipoprotein) lead candidate (SPS-701) program

Preclinical development program for a synthetic high-density lipoprotein candidate intended to address infection complications such as sepsis; funded via a Direct-to-Phase II NIH award to advance toward GLP toxicology.


Services

High-sensitivity quantification of small molecules and biological samples using HPLC and LC-MS/MS to support PK, safety, and toxicology studies.

Formulation design and optimization to improve solubility, stability, and delivery characteristics for preclinical candidates.

Program planning and scientific guidance to close knowledge gaps, align nonclinical data with regulatory expectations, and support development decisions.

Development and co-development of novel delivery systems, including microneedle/microarray patch (MAP) approaches for transdermal drug administration.

Design and conduct of absorption, distribution, metabolism, excretion, and exploratory toxicology studies to inform human dosing strategies and support regulatory planning.

Expertise Areas

  • Preclinical development
  • Formulation development and solubility optimization
  • Drug delivery systems (transdermal microneedle/MAP)
  • Bioanalysis and mass spectrometry
  • Show More (5)

Key Technologies

  • Liquid chromatography (HPLC)
  • Tandem mass spectrometry (LC-MS/MS)
  • Mass spectrometry-based analytics
  • Microneedle / microarray patch (MAP) delivery technology
  • Show More (4)

News & Updates

Announcement that an emerging company established operations within TSRLabs' Ann Arbor facility to enable co-location and collaboration.

Public announcement of corporate rebranding to TSRLabs, including updated identity and website to reflect expanded laboratory and development capabilities.

TSRL participated in a published study reporting in vitro activity of a methionyl-tRNA synthetase inhibitor against resistant gram-positive organisms.

Company CEO discussed TSRLabs' early-stage drug development work and microneedle patch efforts on an Ann Arbor podcast.

Award of a Phase II SBIR grant (R44) to advance a microneedle patch program for overactive bladder therapy.

Company has secured multiple NIH grants across programs, including awards to support microneedle patch development, sHDL program advancement, and antibacterial/antiviral projects.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.